GV1001 reduces pathological 4R tau and functional deficits in models relevant to progressive supranuclear palsy.

Sci Rep · 2026 · PMC12979786 · PMID 41796200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The group administered with LMTM, a tau aggregation inhibitor that does not directly regulate neuroinflammation, showed a decreasing trend in TSPO levels but it was not statistically significant.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.